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ABSTRACT
In interstitial photodynamic therapy, light is distributed to
the tumor via light diffusers. The light dose and the related
phototoxic effect achieved throughout the target volume criti-
cally depend on absorption, scattering and diffuser position-
ing. Using liquid tissue phantoms, we investigated the
dependencies of treatment light transmission and protopor-
phyrin IX (PpIX) fluorescence on these parameters. This
enabled monitoring hemoglobin oxygenation and methe-
moglobin formation during irradiation (635 nm, 200
mW cm1 diffuser length). Starting with two parallel cylin-
drical diffusers at 10 mm radial separation, the light trans-
mitted between the fibers was largely determined by the
minimal distance between the diffusers, but rather insensitive
to an additional axial displacement or tilting of one fiber with
respect to the other. For fixed distance between the diffusor
centers, however, tilting up to direct contact resulted in a 10-
fold signal increase. For hemoglobin within erythrocytes,
irradiation leads to photobleaching of PpIX without marked
change in hemoglobin oxygenation until hemolysis occurs.
Afterward, hemoglobin is rapidly deoxygenized and methe-
moglobin is formed, leading to a dramatic increase in absorp-
tion. For lysed blood, these effects start immediately. A
comparison of intraoperative monitoring of the signals with
the experimental results might help prevent insufficient treat-
ment by reconsidering treatment planning or prolonging
irradiation.
INTRODUCTION
The 5-aminolevulinic acid (5-ALA) has obtained worldwide
clinical approval as a prodrug of protoporphyrin IX (PpIX) for
fluorescence-guided surgery (FGS) of malignant glioma—most
recently by the FDA in USA (1). Numerous studies have
shown that PpIX accumulation upon oral delivery of 5-ALA at
a dose of 20 mg kg1 bw 3–4 h prior to surgery is highly
tumor-selective, summarized and discussed in (2,3). Especially,
the positive predictive value (PPV) of visible PpIX fluores-
cence proved to be very high, reaching up to 100% in some
clinical studies (4,5). A high PPV is of essential importance in
brain tumor surgery because it excludes resection or treatment
of the normal, functional brain. In other words: whatever brain
tissue does show strong PpIX fluorescence contains tumor and
can usually be resected without risking functional deficits. The
Normal brain accumulates no or only minute amounts of PpIX
(6).
The proven high tumor selectivity of PpIX accumulation stim-
ulated a revival of experimental and clinical studies on photody-
namic therapy (PDT) for malignant glioma (2,7–9). One of the
two main approaches relies on performing fluorescence-guided
surgery first and then irradiating the surgical cavity (9), whereas
the other concept addresses predominantly inoperable or recur-
rent tumors by stereotactic interstitial irradiation (8). In this latter
case, cylindrical diffuser fibers are inserted into the tumor after
careful planning of appropriate trajectories, which exclude inju-
ries of blood vessels and other critical structures but allow for
distribution of a sufficient amount of light to the entire tumor
volume.
A favorable feature of PpIX in this context is its fast photo-
bleaching. Due to the irregular shape of malignant glioma, there
is always a high probability that normal brain tissue receives
rather high light doses even with very careful pretreatment plan-
ning. Fortunately, it was reported that the accumulation of PpIX
in normal brain tissue, gray and white matter, is very low com-
pared to the target brain tumor (10). Furthermore, it can be
assumed that during illumination the little amount of PpIX accu-
mulated in normal brain cells will be photobleached before a
lethal amount of reactive oxygen species (ROS) is produced (8).
This is an important inherent safety feature of 5-ALA-based
interstitial PDT of malignant glioma, strongly relaxing light
dosimetry considerations of this approach (8). However, a deeper
clinical investigation on whether the potential therapeutic advan-
tage is compromised by the observation that gray matter appears
to be more sensitive to PDT-induced damage than tumor tissue
would be desirable (10).
In order to monitor photobleaching during interstitial PDT,
spectral online monitoring (SOM) was established to assess the
average PpIX fluorescence in the tumor volume between adjacent
treatment fibers at least prior to and after PDT irradiation
(11,12). In addition to PpIX fluorescence, the treatment light
transmission (at 635 nm) could be monitored between adjacent
fibers. Only one of the cylindrical diffuser fibers was connected
*Corresponding author email: Christian.Heckl@med.lmu.de (Christian Heckl)
†This article is part of a Special Issue dedicated to Dr. Jarod Finlay.
‡This manuscript is part of the inaugural thesis of Christian Heckl to be submitted
at the Medical Faculty of the Ludwig-Maximilians-Universit€at, Munich.
© 2019 The Authors. Photochemistry and Photobiology published by Wiley Peri-
odicals, Inc. on behalf of American Society for Photobiology
This is an open access article under the terms of the Creative Commons Attribution
License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited.
388
to the laser output port at a time for these measurements, while
the other fibers were sequentially connected to a spectrometer
and thus served as light detectors. The recorded spectra showed
an intensity maximum at 635 nm and another one at 700 nm,
corresponding to treatment light transmission and PpIX fluores-
cence, respectively. In order to account for the huge intensity dif-
ferences of both signals, a long-pass filter was included in the
detection beam path, rejecting most of the laser light.
Because tissue optical properties at the excitation wavelength
of 635 nm and the emission wavelength of PpIX at around
700 nm are not identical, the interpretation of the acquired
SOM-spectra is unfortunately not straightforward. However, it
would be good, if one could at least roughly draw immediate
conclusions from the acquired spectra: Whether the laser light
transmission is in an acceptable range, or whether there is
enough PpIX between fibers, where proliferating tumor tissue is
expected. As the absolute intensities are strongly dependent on
the distance, this may also be the case for the ratio of 700 nm
PpIX fluorescence intensity versus 635 nm laser light transmis-
sion also. The primary aim of the present investigation is to
experimentally assess the dependence of light signals measured
between one pair of cylindrical diffuser fibers on the relative
position and orientation of the fibers with respect to each other.
The intraoperative SOM measurements performed in (11,12)
resulted in interesting and unexpected observations regarding the
intensity and/or dynamics of the recorded transmitted laser light.
For example, occasionally, the transmitted intensity dropped to
undetectable levels after PDT. Such strong PDT-induced
changes in optical tissue properties have only been reported a
few other times: In a proceedings paper, Andrade et al. (13)
reported about white light remission spectroscopy they had per-
formed on 5-ALA treated normal mouse skin. In their investiga-
tion, PDT was more efficient in reducing oxygen saturation and
generating methemoglobin (met-Hb) than radiotherapy. As
deoxygenated hemoglobin (deoxy-Hb) and met-Hb have a sig-
nificantly higher molar absorption at 635 nm than oxygenated
hemoglobin (oxy-Hb), this observation translates into an increase
of tissue absorption. Hamada et al. (14) had irradiated red blood
cells dissolved in photosensitizer (talaporfin) solution and moni-
tored absorption spectra during irradiation at a wavelength of
664 nm. Other than some hemolysis, they found the expected
reduction in oxygen saturation and the formation of met-Hb. In
an earlier investigation, Larsen et al. (15) had found met-Hb for-
mation in a rat bladder tumor model, in which some of the ani-
mals the relative contribution to overall oxy-Hb was up to 40%
after 5-ALA-based PDT. Interestingly, met-Hb has a broad
absorption peak at ca. 630 nm, where oxy-Hb is far less absorb-
ing (27 times less) and even deoxy-Hb absorbs about 3.5 times
less (Fig. 3C). It is well known that ROS, for example, pro-
duced by photosensitizers, is able to oxidize hemoglobin to met-
Hb (16) as is also with heating to above 60°C (17). If relevant
amounts of deoxy-Hb and met-Hb were produced within the
PDT treatment volume, this has consequences for light dosime-
try because of spectral changes in absorption. Especially, for
interstitial PDT, the formation of met-Hb during PDT may have
a significant influence on overall tissue absorption and spatial
light distribution at the treatment wavelength of 635 nm. If
cylindrical diffuser fibers are several optical penetration depths
apart from each other, the light transmission losses due to even
moderate increase in absorption potentiate accordingly. It can be
hypothesized that the occasionally observed loss of treatment
light transmission between fibers after interstitial PDT with
glioma patients (11) may therefore at least partly be caused by
the ROS-induced formation of deoxy- and met-Hb. Therefore, it
was the second aim of the present investigation to experimen-
tally assess the dynamics of laser light transmission between one
pair of cylindrical diffuser fibers while recording the spectral
changes of white light transmission indicating changes in hemo-
globin (oxy- versus deoxy- and met-Hb).
MATERIALS AND METHODS
Phantom preparation. To simulate the optical properties of biological
tissue, liquid phantoms with India ink (29770, Rohrer & Klingner
Leipzig-Co., Zella-Mehlis, Germany) or blood (see details below) as
absorber, Lipoven€os (Lipoven€os MCT 20%, Fresenius, Bad Homburg,
Germany) as scatterer, Tween 20 (P1379, Sigmar Aldrich, St. Louis,
Missouri), Protoporphyrin IX (PpIX) (Protoporphyrin IX, Sigmar
Aldrich) as fluorochrome and phosphate-buffered saline (PBS) (P5493,
Sigmar Aldrich) as medium were prepared. The concentrations of the
absorption medium and scattering medium were chosen to represent
physiological absorption and scattering coefficients of the normal brain or
brain tumor tissue at 635 nm (18–20). As base values, absorption and
scattering coefficients µa = 0.02 mm
1 and µs0 = 2 mm
1, respectively,
were used. These values were previously measured intraoperatively for
brain adjacent tumor tissue (20,21). Phantoms of varying absorber (India
ink) concentrations from 0.025&, 0.05&, 0.1&, 0.15& and 0.2& were
created to represent a range of physiologically expected absorption
coefficients µa of (0.02, 0.04, 0.07, 0.10, 0.14) mm
1, respectively. By
using India ink as absorber, a slightly lower absorption coefficient occurs
at 700 nm of about 10% in comparison to the one at 635 nm.
Additionally, different reduced scattering coefficients were simulated by
different concentrations of Lipoven€os, varied from 1%, 1.5%, 2%,
2.5% and 3% representing µs0 of (1.2, 1.8, 2.3, 3.5, 4.6) mm1,
respectively. The optical properties of the phantoms were measured using
the integrating sphere technique as described by others (22). As a
fluorochrome, PpIX powder was dissolved in DMSO at a concentration
of 1 g L1 to prepare a stock solution and further diluted with PBS to
final sample concentrations of 10 or 20 µmol L1, which are reported as
being physiological concentrations found in glioblastoma tissue after oral
application of 20 mg kg1 bw of 5-ALA (6). A concentration of 5 %
Tween20 prevents aggregation of PpIX molecules, which would
influence the measured transmission and fluorescence signals (23). The
phantom was replenished with PBS.
For investigating the potential PDT-induced effects on hemoglobin,
similar liquid phantoms, but with blood as absorber were prepared.
Venous blood was taken from healthy volunteers (University Hospital
LMU Munich ethics protocol: 18–144). The blood was either used imme-
diately or stored in a refrigerator. Prior to adding blood to the liquid
phantoms, it was centrifuged at 2500 rpm for 5 min (121 g) and the
supernatant (plasma) was removed. The sedimented erythrocytes were
then either diluted the original volume with PBS to obtain a blood-equiv-
alent with intact, but “washed” erythrocytes or with distilled water to
obtain lysed blood. To remove all residual constituents except hemoglo-
bin from the lysed blood sample, it was freeze-thawed, centrifuged and
only the supernatant was used for further preparation. Scattering was
adjusted to µs0 = 2.3 mm
1 at 635 nm by adjusting Lipoven€os to 2%
final concentration. A blood concentration of 4% (corresponding to a µa
of 0.03 mm1 at 80% blood oxygenation) was chosen, and the PpIX
concentration used was 20 µmol L1.
Measurement setup and fibers. A diode laser at 635 nm (Ceralas,
Biolitec AG, Vienna, Austria) was calibrated to emit 200 mW cm1
from a 2 cm cylindrical light diffuser fiber (CD-4L3-20, LifePhotonics
GmbH, Bonn, Germany). A second similar fiber was used as a detection
fiber, which was connected to a spectrometer (USB2000+, OceanOptics,
Largo, Fl) which incorporates a 657 nm long-pass filter. The long-pass
filter did not completely block the transmitted laser light, thus enabled
the recording of transmitted laser light and PpIX fluorescence
simultaneously as is done during clinical iPDT (11).
Fluorescence and treatment light detection at different optical
properties and fiber orientations. Clinically, the perfect fiber positioning
is challenging, thus different orientations of the fibers with respect to
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each other were investigated as shown in Fig. 1 which might support
the interpretation of the measured transmitted treatment light and PpIX
fluorescence signals. The fiber positions were investigated with respect
to the distance between two parallel fibers (Fig. 1A), their relative axial
positions (Fig. 1B), their angular deviation to the y-axis at the y-z-plane
at the center of the diffuser tip (Fig. 1C) and the angular deviation to
the y-axis at the y-x-plane (Fig. 1D) until the tips of the two fibers
were in contact. To also evaluate the geometric dependence of the
transmission and fluorescence signals on variable optical tissue
properties, different concentrations of absorber and scatterer were
investigated.
The distance between fibers in Fig. 1A was adjusted to 3, 4, 5, 6, 8,
10, 12, 14, 16, 18 and 20 mm from fiber center to fiber center. The axial
displacement in Fig. 1B was investigated in 5 mm steps to a total dis-
placement of 40 mm. Investigated angles were 0°, 5°, 10°, 20°, 45° and
90° in the configuration of Fig. 1C and 0°, 5°, 10°, 20° and 30° in the
configuration of Fig. 1D. In the setups C and D, the distance d between
the fibers in the middle of the light-emitting diffuser region area was kept
at 10 mm.
Influence of blood absorption during PDT. The experimental setup as
depicted in Fig. 1A with a constant interfiber distance of 10 mm was
used. The volume of the liquid phantoms was 50 mL only, in order to
limit the interaction volume between light and hemoglobin and the
available content of PpIX in this volume, in an attempt to mimic the
clinical situation. The phantom was stirred during the measurement at
200 min1.
During irradiation, white light transmission spectra were collected in
regular intervals with a device, comprising a white light LED, a fiber
bundle probe immersed into the phantom and a spectrometer (AvaSpec-
Mini2048(CL), Avantes, Apeldoorn, The Netherlands). The fiber bundle
consists of six excitation fibers surrounding a single detection fiber, all
fibers having 400 µm cores. Before measuring the phantoms, a reference
spectrum was collected from a phantom with all constituents except
blood. Each measured spectrum was divided by the reference spectrum
prior to storage.
During one of the experiments with washed erythrocytes, 2 mL of the
liquid phantom were withdrawn prior to and at 15 min intervals after the
start of irradiation. These samples were centrifuged (121 g, 5 min) and
20 µL of the supernatant in the central fraction, containing the lowest
concentration of sedimented erythrocytes (bottom fraction) and scattering
lipid (top fraction) were extracted with a 10 µL pipette, diluted 1:100
with PBS and then measured in a cuvette absorption spectrometer (Lamb-
da40, Perkin Elmer, Waltham, Massachusetts). No further measurements
were performed to determine the degree of hemolysis of every single 20
µL sample derived in this way.
Data evaluation. The recorded spectra were evaluated using Matlab
(R2018b, MathWorks, Natick, Massachusetts) and SigmaPlot (v11.0,
Systat Software, Erkrath, Germany). Raw data spectra were averaged
over wavelength intervals of 2 nm. All phantoms were prepared and
measured in at least three independent replicates.
For the evaluation of the influence of blood absorption during iPDT,
the spectra recorded from the detection fiber were evaluated as follows: a
four pixel (2 nm interval) average was calculated for the intensities I(k)
at wavelengths k of 635 nm (laser light transmission), 674 nm (photopro-
duct (PP) fluorescence peak) and 700 nm (second PpIX fluorescence
peak). As the fluorescence spectra IPP(k) and IPpIX(k) of PP and PpIX
overlap, the pure signal contributions IPP(674 nm) of PP at 674 nm and
IPpIX(700 nm) of PpIX at 700 nm were separated using Eqs. (1) and (2):
IPP 674nmð Þ ¼ ðI 674nmð Þ  xPpIX  I 700nmð Þ= 1 xPP  xPpIX
 
ð1Þ
IPpIX 700nmð Þ ¼ I 700 nmð Þ  xPP  I 674 nmð Þð Þ= 1 xPP  xPpIX
 
ð2Þ
where IPP(674 nm) and IPpIX(700 nm) are the signal intensities in counts
per second that would have been recorded at 674 and 700 nm due to the
fluorescence emission intensities of PP and PpIX without overlap, I
(674 nm) and I(700 nm) are the counts per second actually measured on
the examined phantoms at the respective wavelengths, and xPP and xPpIX
are the ratios of the intensities emitted by pure PpIX at 674 and 700 nm
and by pure PP at 700 and 674 nm, respectively. The values for xPP and
xPpIX had been determined to xPP = 0.65 and xPpIX = 0.281 for the spec-
trometer in use.
The recorded white light transmission spectra were fitted with pure
spectra of oxy-Hb, deoxy-Hb and met-Hb (as depicted in the results
Fig. 3C) according to Eq (3). This equation calculates the relative contri-
butions of oxy-Hb, deoxy-Hb and met-Hb to the measured spectrum.
I kð Þ ¼ I0  exp  a  Aoxy kð Þ þ b  Adeoxy kð Þ þ c  Amet kð Þ
   ð3Þ
where I(k) is the model function with fit parameters a, b and c represent-
ing the contributions of the absorption spectra of oxy-Hb (Aoxy), deoxy-
Hb (Adeoxy) and met-Hb (Amet) to the measured spectrum. I0 is another fit
parameter, which is expected to be close to 1 because the measured spec-
tra were scaled to the reference signal obtained on a phantom without
absorber. Spectral ranges with the characteristic shapes of oxyhemoglobin
(530–580 nm) and met-Hb (590–650 nm) were given higher weights (up
to 309) to obtain good fits (compare Fig. 3B). The weighing reduced the
residuals of the difference of measured and fitted spectra, thus improving
Figure 1. Positioning of the emitting and detecting fiber. The graph shows the light-guiding fibers in black, with the diffuser regions in red for the emit-
ting fiber and gray as detecting fiber, respectively. The emitting and detecting fibers were placed parallel to each other at several distances (A) and in
different relative axial positions (B), as indicated by the black arrows. A relative angular deviation within the y-z-plane (C) as well as within the com-
mon y-x-plane (until the tips of the fibers are in contact) (D) were applied to investigate the corresponding signal dependencies for nonparallel fiber
pairs. The x-distances d of the centers of the diffuser regions in the experimental setups B, C and D were fixed at 10 mm.
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the determination of the relative contributions of oxy-Hb, deoxy-Hb and
met-Hb.
RESULTS
Fluorescence and treatment light detection at different
optical properties and fiber orientations
Figure 2 shows the results of the experimental measurements of
the assessment of light penetration at several fiber orientations at
different optical properties. Each graph shows the mean value
with a standard deviation of three measurements independently
taken.
The transmission and fluorescence intensities in graph 2A and
2B are normalized to the measured intensities at 10 mm with an
absorption coefficient of µa = 0.07 mm
1 and a reduced scatter-
ing coefficient of µs0 = 2.3 mm
1 (blue line). As expected, the
detected treatment light decreases roughly exponentially with
increasing (radial) fiber distance. The decay becomes faster with
increasing scattering (B) and in particular with increasing absorp-
tion (A). The detected fluorescence signals behavior similarly to
the transmission signals, albeit with a generally slower decay.
The comparison of the fluorescence intensity and the transmis-
sion intensity is shown in Fig. 2C, where the fluorescence signals
divided by the transmission signals are plotted at different dis-
tances between the emission and the detection fibers at an
absorption coefficient of µa = 0.07 mm
1 and a reduced scatter-
ing coefficient of µs0 = 2.3 mm
1. With shorter distances
between the two fibers, the fluorescence signal reaches 38% and
70.8% of the transmission intensity value at 5 and 8 mm, respec-
tively.
The results of the investigation of two fibers at different rela-
tive axial positions are shown in Fig. 2D, geometry Fig. 1B. This
measurement was implemented with one fixed absorption coeffi-
cient (µa = 0.07 mm
1) and one fixed scattering coefficient (µs0
= 2.3 mm1). The intensity increases while the detection fiber is
pulled from below the emission fiber until the two fibers are par-
allel at the same height. Then, when the detection fiber is moved
until its tip is at the level of the beginning of the diffused emis-
sion area of the emission fiber, the intensity decreases. The mea-
sured intensities are at the same level when the detection fiber is
located above or below the light-emitting diffuser region of the
emission fiber. In the region 10 mm to 10 mm, the deviation
of the transmission intensity is less than 25%.
Fig. 2E shows the results where the detection fiber is tilted
with respect to a y-axis in the y-z-plane, geometry Fig. 1C. It
can be seen that with increasing the angular deviation the mea-
sured transmission intensity decreases by up to 39 %. At small
angular deviations at about 10°, however, an intensity decrease
of only 2.3% occurs.
In case, the fiber geometry was adjusted such that both fibers
were tilted until their tips get in contact, geometry Fig. 1D, the
results are shown in Fig. 2F. As the angular deviation increases,
as the fiber tips approach, the measured transmission intensity
increases by a factor of up to 14.3. At an angular deviation of
10°, an intensity increase occurs by a factor of 2.
Influence of blood absorption during PDT
Liquid phantom measurements with lysed blood or washed ery-
throcytes were performed to detect any PDT-induced changes in
Figure 2. Results of interfiber light transmission and PpIX fluorescence measurements at different optical properties and different relative fiber positions.
Each graph shows the normalized mean value at 635 nm for transmission and 700 nm for fluorescence at 10 mm fiber distance and at µa of 0.07 mm
1
and µs0 of 2.3 mm
1 with a standard deviation of three independent measurements. Graph A and B show the decrease of treatment light transmission
(dotted line) and fluorescence (solid line) intensities between two parallel fibers with increasing distance and with increasing absorption or reduced scat-
tering coefficients, respectively. The distance-dependent ratio of the fluorescence and transmission signals is shown in graph C. Graph D shows the treat-
ment light and fluorescence intensities at different relative axial positions of parallel fibers. The influence of out-of-common-plane and within-common-
plane angular deviations (until the tips are in contact) are shown in graphs E and F, respectively.
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absorption at the irradiation wavelength (635 nm), PpIX fluores-
cence (700 nm photobleaching), PP fluorescence (at 674 nm),
oxy-, deoxy- and met-Hb. Spectra, as recorded by the cylindrical
diffuser fiber serving as a detector, are shown in Fig. 3A. At the
start of irradiation (black line), strong signals are observed, both
for the laser light transmitted from the emission fiber to the
detection fiber (635 nm) and the characteristic PpIX fluorescence
generated within the tissue (peaking at 700 nm). During irradia-
tion, an additional local maximum at 674 nm appears, while the
PpIX fluorescence signal at 700 nm decreases. Interestingly, the
transmitted laser light detected at 635 nm decreases as well, indi-
cating increasing light absorption at 635 nm within the tissue, as
the output of laser light from the irradiating diffuser remained
constant throughout the experiment. The source of this increase
in absorption becomes obvious from Fig. 3B: At the start of irra-
diation (black line), the white light transmission spectra show the
imprint of mostly oxy-Hb. During irradiation, the contributions
of deoxy-Hb and potentially met-Hb were detected (indicated by
the additional minimum at around 635 nm after 60 min and veri-
fied by the local absorption maximum of met-Hb shown in
Fig. 3C).
Figures 4 and 5 depict, the time-dependent signals of laser
light transmission, PpIX and PP fluorescence (graph A), as well
as the fit contributions (fit parameters a, b and c Eq. (3)) of oxy-,
deoxy- and met-Hb (graph B). Figure 4 shows the results obtained
for samples with lysed blood, while Fig. 5 shows the results for
samples, where washed erythrocytes were added to the same
final blood volume. In both cases, the absorption at 635 nm at
the end of irradiation was much higher than at start, leading to a
signal reduction by two orders of magnitude (black lines in the
graphs A). The PpIX fluorescence signal was also decreasing
with time. The signal decrease detected at 700 nm could be
caused by an increase of absorption at the excitation and/or the
emission wavelengths and/or by PpIX-photobleaching. Since the
absorption changes could be caused by a variety of substances
with different spectral characteristics, for example, different
hemoglobin species, absorption and photobleaching effects could
not be quantitatively separated from each other within our exper-
imental approach. As visible in the green curve, photoproduct
(PP) was formed shortly after the onset of irradiation. The related
signal then decreased, potentially also due to photobleaching,
together with the PpIX signal. In Figures 4 and 5, Graphs B
show almost the same contributions of the different hemoglobin
species at the start of irradiation. Also, in both cases deoxy-Hb
increases at the cost of oxy-Hb, while fitted met-Hb was formed
at a slower rate, but finally continues to increase at the cost of
deoxy-Hb, leading to a maximum of the deoxy-Hb signal as
soon as oxy-Hb had disappeared almost completely. The most
striking differences between lysed blood (Fig. 4) and washed
erythrocytes (Fig. 5) are threefold:
1 With lysed blood, there is an immediate onset of treatment
light transmission reduction and deoxygenation of hemoglobin,
while these signals stay relatively constant for a while in the
case of washed erythrocytes, although PpIX is clearly photo-
bleaching.
2 Less overall PP formation in the case of lysed blood.
3 An obviously steeper decrease of laser light transmission and
related signals in the case of washed erythrocytes as soon as
the initial “lag-phase” has passed.
Figure 6 indicates that when irradiating washed erythrocytes
in the phantom experiment, the erythrocytes are destroyed at
least partially, as evident by the characteristic hemoglobin
absorption observed in the supernatant of centrifuged phantoms,
which gets more and more pronounced with increasing irradia-
tion time beforehand. Hemolysis seems to be largely completed
already at 15 min after the start of irradiation, which is earlier
than the onset of the fast absorption increase at 30–40 min as
shown in Fig. 5A. However, the centrifugation did not separate
the layers very clearly and withdrawing a clear layer without
scattering was not possible. A quantitative interpretation of the
absorption spectra is therefore not possible.
DISCUSSION
Fluorescence and treatment light detection at different
optical properties and fiber orientations
The investigations of different fiber arrangements demonstrated a
moderate dependence on axial displacements and angular
Figure 3. Graph A: Time-dependent spectral changes as measured with a spectrometer connected to the detecting fiber after low pass filter. Sample with
washed erythrocytes. The Peak at 635 nm: treatment light transmission, peak at 700 nm: PpIX fluorescence, peak at 674 nm: PP fluorescence. Graph B:
Time-dependent white light transmission spectra with respect to a nonabsorbing reference sample (solid lines). Sample with lysed blood. Dashed lines:
the result of curve fit according to Eq. (3). Graph C: Blood absorption spectra used for fitting.
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deviations within the y-z-plane, while the signal increases more
than 10-fold if the fiber tips get in contact due to angular devia-
tion within the y-x-plane. This should be kept in mind during
treatment planning. Of course, it will always be intended to plan
the fiber trajectories as parallel to each other as possible, but the
location of vulnerable structures and larger blood vessels fre-
quently require some deviation from this strategy. It becomes
obvious that unavoidable angular deviations should be imple-
mented under careful consideration of the relative positions of
adjacent fibers. Fortunately, none of these deviations from the
treatment plan lead to a signal decrease by more than a factor of
2, as long as the shortest distance between the fibers is close to
10 mm. The strong signal increase resulting from angular devia-
tions within the y-x-plane (Fig. 2F) would not impede PDT as
long as dose-volume histograms indicate sufficient tumor cover-
age, but it could produce undue tissue heating and should, there-
fore, be avoided.
The slopes of the distance-dependent fluorescence signals
(Fig. 2A,B) are considerably less steep than the slopes of the
corresponding treatment light transmission signals. This is due to
Figure 4. Results of experiments with lysed blood. Graph A: Time-dependent signals of transmitted treatment light (black line), PpIX fluorescence (red
line) and PP fluorescence (green line). Graph B: Time-dependent fit parameters for the contributions of oxy-Hb (black line), deoxy-Hb (red line) and
met-Hb (green line).
Figure 5. Results of experiments with washed erythrocytes. Graph A: Time-dependent signals of transmitted treatment light (black line), PpIX fluores-
cence (red line) and PP fluorescence (green line). Graph B: Time-dependent fit parameters for the contributions of oxy-Hb (black line), deoxy-Hb (red
line) and met-Hb (green line).
Figure 6. Transmission spectra of the transparent component of cen-
trifuged samples from phantoms with washed erythrocytes prior to and at
different times after the start of irradiation.
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the somewhat lower absorption and scattering at the emission
wavelength compared to the excitation wavelength. As a conse-
quence, both signals decrease with increasing distance, but the
fluorescence intensity less so than the transmitted treatment light.
Fig. 2C, clearly indicates the ratio of the corresponding peak
heights detected for parallel diffusers and the parameter combina-
tion µa of 0.07 mm
1 and µs0 of 2.3 mm
1, normalized to 1 for
the used “standard conditions” at 10 mm separation.
A closer look at the µs0 variations of the distance-dependent
signals in Fig. 2B (at a fixed absorption) shows converging
curves at a shorter distance and even crossovers. This is to be
expected, as multiple scatter may return light from larger dis-
tances, an effect which also leads to increased light intensities
underneath the tissue surface if scatter dominates absorption
(24).
Provided the fiber-based signal detection is carefully cali-
brated, Fig. 2A,B allow deducing the expected absolute signal
intensities for a given interfiber distance for both the laser light
transmission and the PpIX fluorescence. As the curves are rather
steep, the interfiber distance has to be known precisely to draw
quantitative conclusions: an uncertainty of 1 mm can lead to a
2-fold higher or lower intensity. On the other hand, a signifi-
cantly higher absorption than planned has an even stronger influ-
ence on the measured signals. If the treatment planning was
done with assuming µa = 0.02 mm
1 for instance, but in fact
was µa = 0.07 mm
1, fluorescence and treatment light signals
are reduced by a factor of 20–40 (at 10 mm fiber distance). If
the transmission signal is significantly (about 10-fold) lower than
expected, the suspicion of having induced some capillary bleed-
ing may be justified. Lilge et al. (10,25) reported to local
changes in the tissue optical properties following iPDT for
intracranial VX2 tumors, referring to local hemorrhage around
fiber tips, vasodilatation, vasoconstriction and small changes in
blood content in the tissue as possible explanations. The fibers
concerned should then be given treatment light as soon as possi-
ble to minimize the loss of PDT efficiency by blood absorption
and hemoglobin transformation. A final judgment of the rele-
vance of such assumptions will be possible, as soon as sufficient
clinical data are available.
In interstitial photodynamic therapy of brain tumors, several
cylindrical diffuser fibers are placed into the tumor (11). For all
fiber pairs, transmission and fluorescence measurements can be
performed and the average optical tissue parameters and PpIX
fluorescence can be calculated. For this evaluation, knowledge of
the 3D coordinates of the fiber trajectories are required. If such
spectral measurements are performed before the start of irradia-
tion, the information can be used to adjust light dosimetry and
thus to perform a patient individualized therapy. A similar
approach has previously been described by Finlay et al. (26) for
iPDT of the prostate, where isotropic emitters and detectors are
moved along the trajectories within transparent catheters. The
authors could measure the photosensitizer concentration by
recording absorption spectra because the photosensitizer used has
a higher absorption at longer wavelengths (MLu absorbs at
735 nm). This is not a realistic option for PpIX, but the fluores-
cence at 700 nm can easily be detected and when the tolerable
range of signal intensities prior to and after PDT (then reduced
via photobleaching) is known, appropriate conclusions may be
drawn, for example, to prolong irradiation, if photobleaching is
not achieved to a sufficient degree.
Influence of blood absorption during PDT
During interstitial PDT of malignant glioma, it was previously
observed that the transmission of laser light at 635 nm between
adjacent cylindrical diffuser fibers (ca. 10 mm apart) usually
stays constant over the 1 h irradiation time with 200 mW cm1
diffuser length (11). But there are also cases, where a gradual
decrease in laser light transmission between fibers could be
observed. Sometimes there was hardly any signal detectable after
PDT. One may speculate that during insertion of the diffuser
fibers into the tumor, some capillaries may be ruptured and cause
some bleeding around the fiber tips. However, a continuous
whole blood layer would have to become more than 300 µm
thick in order to explain a 90% loss of transmission (27). An
equivalent signal loss would be induced by an increase in blood
volume–fraction in the entire tissue, for example, from 4% to
about 11%, as obtained from calculations for a point source, dif-
fusion approximation and µa = 0.02 mm
1 and µs0 = 2 mm
1,
which corresponds reasonably well with Fig. 2A. A similar trend
could be induced by an oxygenation of hemoglobin within the
treated volume. Such an effect has, in fact, been claimed as indi-
cated in the introduction (14,15) and attributed to the interaction
of a photosensitizer with hemoglobin, which leads to the forma-
tion of deoxy-Hb and met-Hb at the cost of initially dominating
oxy-Hb. Finlay et al. also (26) reported on a PDT-induced
increase of deoxy-Hb detected by white light absorption spec-
troscopy. Met-Hb can also be induced by heating to above 60°C.
We could exclude thermal met-Hb formation in our experimental
conditions by detecting no changes in Hb signals at all if PpIX
was not added to the phantom (data not shown).
Under “regular” conditions during PpIX-based iPDT, the pho-
tosensitizer PpIX inside the tumor cells is well separated from
the hemoglobin inside erythrocytes traveling in blood vessels. In
addition, as long as there is perfusion, there will always be new,
well-oxygenated, hemoglobin continuously replacing any deoxy-
Hb. If there is some interstitial bleeding, however, such erythro-
cytes might potentially remain in the treatment region and some
extracellular PpIX might then interact with these erythrocytes.
Our experiments with washed erythrocytes are in accordance
with the assumption that as long as the hemoglobin is well
packed in erythrocytes, there is little to no access of singlet oxy-
gen to the hemoglobin in the erythrocytes. Transmission stays
rather stable. Meanwhile, PpIX is clearly undergoing some pho-
tobleaching, obviously consuming oxygen dissolved in the sur-
rounding. It takes considerable time (at least 20 min under our
experimental conditions) to allow the photosensitizer sufficient
access to the hemoglobin. Extracts of the sample clearly show
ongoing hemolysis at this time (Fig. 6). Interestingly, once the
erythrocytes are destroyed, the hemoglobin deoxygenation occurs
at a rate at least as fast as in the case of lysed blood. This is
astonishing because the PpIX has already been photobleached to
below 20% at this time. The only plausible explanation for this
observation we can think of is that most of the dissolved oxygen
has been used up at this time, and the further generation of sin-
glet oxygen is then restricted to the conversion of oxygen bound
in hemoglobin, seeing a steeper O2 gradient. In two other inde-
pendent experiments on hemoglobin samples using the same pro-
cedure, the obtained composition parameters showed a very
similar behavior in each case (see Supporting Informa-
tion, Figs. S1 and S2). Only the time after which singlet oxygen
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in the erythrocytes receives access to hemoglobin varies between
20 and 40 min among the experiments.
The observation of PDT-induced formation of deoxy-Hb and
met-Hb in optical tissue phantoms with blood may have very rel-
evant clinical implications. If the mechanical insult on the brain
tumor tissue during insertion of the light diffuser fibers induces
some hemorrhage, tissue absorption may not only increase due
to the increased blood volume fraction but also by the formation
of much stronger absorbing deoxy-Hb and met-Hb during the
subsequent irradiation. As a consequence, one should aim for
minimizing the time delay between fiber insertion and the start
of irradiation. This minimizes both effects. Monitoring of the
laser light transmission between light diffusers before and after
irradiation provides valuable information on whether and how
severely tissue absorption may have increased. A systematic
recording of such events for multiple patients should finally clar-
ify the relative contributions of an increase in blood volume frac-
tion and PDT-induced effects to increases in tissue absorption. If
an intracavity PDT is to be performed after tumor resection, it
must be ensured before starting the irradiation that as little blood
as possible is present on the cavity walls because potentially sim-
ilar conversion processes can be induced during irradiation. One
should mention that tissue hypoxia might also lead to increased
absorption due to an increased proportion of deoxy-Hb with
implications for treatment efficacy (28).
The fits of pure hemoglobin spectra to the measured white
light transmission spectra were of limited quality. One possible
reason is the probe geometry, which does not allow for recording
well-controlled, plain absorption or transmission spectra. The
average light path length will vary with absorption, underestimat-
ing stronger absorption due to a reduction in effective path
length. This deficit might be minimized by applying a more elab-
orate analysis, for example, as presented by Finlay and Foster in
(29). However, the qualitative differences between lysed blood
and intact erythrocytes would not change. Here, we were not
interested in quantifying blood oxygen saturation in untreated tis-
sue, but in identifying any PDT-induced changes in hemoglobin
absorption at 635 nm. Another reason is the relatively restricted
emission bandwidth of the white light LED with rather limited
intensities at short and long wavelengths. The absolute values of
the contributions of the different hemoglobin species should
therefore not be overinterpreted in a quantitative manner.
The validity of the phantom experiments is limited, as vital
biological tissue may be discussed as follows: In vital tissue,
photosensitizer and hemoglobin are well separated, which was
also the case in half of the comparative phantom experiments.
The liquid phantom samples were prepared in 50 ml containers
and were gently stirred continuously. This volume is consider-
ably larger than the typically irradiated tissue volume during
iPDT (4–8 mL per fiber). On the other hand, in vital tissue, the
blood fraction within the tissue is connected to blood vessels and
is therefore continuously exchanged, which means that it will not
take part in the dynamic PDT-induced effects. Only hemorrhage
will lead to amounts of blood resting in a certain tissue region,
starting from very low blood volume fractions, while in the
phantoms the blood volume fraction is constant and recruited
from the same 50 ml volume over the full observation time.
These differences may partly compensate each other in terms of
the time-dependent signal evolution. Another difference is the
exposure to PpIX. In our experiments, PpIX was added shortly
before the start of irradiation. Still, there were a few minutes of
“drug light interval” and may have led to the different lag times
of erythrocyte destruction observed in Fig. 5. If PpIX had some
time to diffuse into erythrocytes, the time to onset of hemoglobin
transformation may be shorter. It is unknown, how much of
extracellular PpIX is present in viable glioblastoma tissue. In any
case, the sooner irradiation starts after insertion of the fibers, the
less the risk of early hemoglobin transformation, absorption
increase and insufficient treatment.
We are confident that the phantom experiments are realistic
enough to point out a possibly important phenomenon to be con-
sidered for iPDT. The details of the kinetics of the onset and
speed of hemoglobin deoxygenation and met-Hb formation may
be different, but that it can occur in case of hemorrhage and that
it can vary significantly alter the light distribution and thus affect
the therapeutic irradiation should be well considered, and the
effect should be monitored intraoperatively.
In summary, this manuscript shows:
1 Light transmission between cylindrical diffuser fibers as inves-
tigated in this work did not strongly depend on relative fiber
positions or orientations as long as the minimal distance
between the diffusor regions remained unchanged.
2 As fluorescence light undergoes less absorption and scattering
than treatment light, the relative intensity of the PpIX fluores-
cence signal increases with increasing distance.
3 PDT can induce deoxygenation and met-Hb formation in immo-
bilized blood (after hemorrhage for example), which strongly
increases the absorption at 635 nm. This may contribute to the
clinically observed occasional loss of treatment light transmis-
sion between adjacent diffuser fibers during PDT.
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SUPPORTING INFORMATION
Additional supporting information may be found online in the
Supporting Information section at the end of the article:
Figure S1. Results of independent replicates with lysed ery-
throcytes to the results of Figure 4 of the main publication. In
the two left graphs, the time-dependent signals of transmitted
treatment light (black lines), PpIX fluorescence (red line) and PP
fluorescence (green line) are depicted. The right graphs show the
time-dependent fit parameters for the contributions of oxy-Hb
(black line), deoxy-Hb (red line) and met-Hb (green line).
Figure S2. Results of independent replicates with washed ery-
throcytes to the results of Figure 5 of the main publication. In
the two left graphs, the time-dependent signals of transmitted
treatment light (black lines), PpIX fluorescence (red line) and PP
fluorescence (green line) are depicted. The right graphs show the
time-dependent fit parameters for the contributions of oxy-Hb
(black line), deoxy-Hb (red line) and met-Hb (green line).
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